Belgium-based mind imaging AI firm icometrix introduced it acquired a CPT III code from the American Medical Affiliation enabling reimbursement of its FDA-cleared mind MRI quantification software program.
icometrix AI-supported quantitative mind evaluation software program offers metrics for cerebral MRI scans to assist clinicians diagnose, monitor and consider therapy responses in sufferers with neurological circumstances, similar to Alzheimer’s and dementia, a number of sclerosis, epilepsy, stroke and Parkinson’s illness.
The CPT code will enable certified healthcare professionals to report their use of icometrix mind imaging AI software program as a follow expense.
THE LARGER TREND
The corporate acquired $18 million in funding in 2019 to develop its mind software program. The Belgium firm garnered FDA clearance for its icobrain-ctp providing in February 2020.
Final month, the corporate announced it was awarded a grant from the Michael J. Fox Foundation to analysis mind MRI biomarkers for Parkinson’s illness in collaboration with a neurology and neurological sciences professor at Stanford Medicine.
In March, the corporate acquired a £1,417,658 ($1,798,944) grant from the National Institute for Health and Care Research to speed up analysis within the imaging of a number of sclerosis.
One other firm utilizing AI software program to assist suppliers diagnose mind issues is South Korean well being tech firm Neurophet. In April, it obtained certification from Singapore’s Well being Sciences Authority for its AI-enabled degenerative mind illness analysis assistant software program.
